Tune in for a great discussion with Ben Nacev, MD PhD 👇👇👇!

Novartis BRAF-MEK inhibitor combo (Tafinlar-Mekinist) receives tumor-agnostic FDA approval for malignancies carrying BRAF V600E.

#GIST #sarcoma #targetedtherapy #cancertreatment NovartisCancer

Note that some #GIST carry a BRAF V600E mutation...

Finally some answers!!! 🙏🙏🙏
Now we just need someone to translate this knowledge into specific repellents... Cell

Differential mosquito attraction to humans is associated with skin-derived carboxylic acid levels cell.com/cell/fulltext/…

Once when I was young, around 8 or so, we had a garage sale. My siblings and I were killing time riding our bikes along the sidewalk and this guy stopped in. But he wasn't there to buy anything.

He went up to my mom, introduced himself and said he'd stopped because he saw us...

Exciting new lab opportunity for #sarcoma #research with new faculty member Ben Nacev, MD PhD at UPMC Hillman Cancer Center Pitt Health Sciences !!
APPLY!!!
👇👇👇

Great to have you here, Ben Nacev, MD PhD ! Very much looking forward to exciting collaborations, moving #sarcoma #research , PSaRC , forward together! UPMC Hillman Cancer Center Pitt Health Sciences Pittsburgh Cure Sarcoma

Please join us in welcoming Benjamin A. Nacev, MD, PhD, to UPMC Hillman Cancer Center. Dr. Nacev will lead a basic and translational laboratory focused on epigenetic dysregulation in sarcomas. Ben Nacev, MD PhD Pitt Health Sciences

Wow... Wait 'til the end!
🎶

A Clinical Cancer Research Translations piece by our PSaRC members Kurt Weiss and Kelly Bailey MD, PhD:

doi.org/10.1158/1078-0…

Very cool study!! 👇👇

Undetected KIT and PDGFRA mutations: an under-recognised cause of gastrointestinal stromal tumours (GISTs) incorrectly classified as wild-type - Pathology pathologyjournal.rcpa.edu.au/article/S0031-…

Very interesting concept! And yes, seems really good for undergraduate research, I agree. Need to look into this in more detail!

So true!!
Thank you for being a great #collaborator , Riyue Sunny Bao, PhD !

😳🍪📊🤩🤯

Monica Bertagnolli (Harvard Medical School, Brigham and Women's Hospital, Dana-Farber) to serve as next National Cancer Institute director. She will be the first woman in the role. Read her guest editorial from 2019 written during her ASCO presidency: cancerletter.com/trials-and-tri…

NLMSF - SPAG INTERNATIONAL RESEARCH ROUNDTABLE FOR RESEARCHERS ONLY- Scientific Think Tank Oct 21 - 22 - Email annieachee for details and registration. or call 303 808-3437 Four focus workgroups involved in this: Clinical Trials, Cell Lines,OMICS, Gyne, Imaging-Radiomics